Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Physician-led in-hospital multidisciplinary team conferences with multiple medical specialities present - A scoping review.
Henriksen DP, Ennis ZN, Panou V, Hangaard J, Jensen PB, Johansson SL, Nagarajah S, Poulsen MK, Rothmann MJ, Schousboe K, Bugge SJ, Jessen LB, Schneider IR, Olsen Zwisler AD, Højlund K, Damkier P. Henriksen DP, et al. Among authors: hojlund k. J Multimorb Comorb. 2022 Dec 7;12:26335565221141745. doi: 10.1177/26335565221141745. eCollection 2022 Jan-Dec. J Multimorb Comorb. 2022. PMID: 36518524 Free PMC article. Review.
Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme.
Sperling S, Stokholm L, Thykjaer AS, Pedersen FN, Möller S, Laugesen CS, Andersen N, Andresen J, Bek T, la Cour M, Hajari J, Heegaard S, Højlund K, Kawasaki R, Kolko M, Schielke KC, Rubin KH, Vestergaard AH, Grauslund J. Sperling S, et al. Among authors: hojlund k. Acta Ophthalmol. 2023 Jun;101(4):384-391. doi: 10.1111/aos.15300. Epub 2022 Dec 13. Acta Ophthalmol. 2023. PMID: 36514165
Effects of DPP-4 inhibitors, GLP-1 receptor agonists, SGLT-2 inhibitors and sulphonylureas on mortality, cardiovascular and renal outcomes in type 2 diabetes: A network meta-analyses-driven approach.
Brønden A, Christensen MB, Glintborg D, Snorgaard O, Kofoed-Enevoldsen A, Madsen GK, Toft K, Kristensen JK, Højlund K, Hansen TK, Søndergaard E, Hansen KB. Brønden A, et al. Among authors: hojlund k. Diabet Med. 2023 Aug;40(8):e15157. doi: 10.1111/dme.15157. Epub 2023 Jun 12. Diabet Med. 2023. PMID: 37249579 Review.
Diabetic retinopathy is a predictor of chronic respiratory failure: A nationwide register-based cohort study.
Thinggaard BS, Stokholm L, Davidsen JR, Larsen MC, Möller S, Thykjær AS, Andresen JL, Andersen N, Heegaard S, Højlund K, Kawasaki R, Laugesen C, Bek T, Grauslund J. Thinggaard BS, et al. Among authors: hojlund k. Heliyon. 2023 Jun 19;9(6):e17342. doi: 10.1016/j.heliyon.2023.e17342. eCollection 2023 Jun. Heliyon. 2023. PMID: 37426795 Free PMC article.
Accelerometer-derived physical activity and sedentary behaviors in individuals with newly diagnosed type 2 diabetes: A cross-sectional study from the Danish nationwide DD2 cohort.
Domazet SL, Tarp J, Thomsen RW, Højlund K, Stidsen JV, Brønd JC, Grøntved A, Nielsen JS. Domazet SL, et al. Among authors: hojlund k. Front Sports Act Living. 2023 Jan 25;4:1089579. doi: 10.3389/fspor.2022.1089579. eCollection 2022. Front Sports Act Living. 2023. PMID: 36761371 Free PMC article.
Empagliflozin to elderly and obese patients with increased risk of developing heart failure: Study protocol for the Empire Prevent trial program.
Andersen CF, Larsen JH, Jensen J, Omar M, Nouhravesh N, Kistorp C, Tuxen C, Gustafsson F, Knop FK, Forman JL, Davidovski FS, Jensen LT, Højlund K, Køber L, Antonsen L, Poulsen MK, Schou M, Møller JE. Andersen CF, et al. Among authors: hojlund k. Am Heart J. 2024 May;271:84-96. doi: 10.1016/j.ahj.2024.02.005. Epub 2024 Feb 15. Am Heart J. 2024. PMID: 38365073 Free article.
Five-Year Incidence of Proliferative Diabetic Retinopathy and Associated Risk Factors in a Nationwide Cohort of 201 945 Danish Patients with Diabetes.
Dinesen S, Stokholm L, Subhi Y, Peto T, Savarimuthu TR, Andersen N, Andresen J, Bek T, Hajari J, Heegaard S, Højlund K, Laugesen CS, Kawasaki R, Möller S, Schielke K, Thykjær AS, Pedersen F, Grauslund J. Dinesen S, et al. Among authors: hojlund k. Ophthalmol Sci. 2023 Feb 24;3(3):100291. doi: 10.1016/j.xops.2023.100291. eCollection 2023 Sep. Ophthalmol Sci. 2023. PMID: 37025947 Free PMC article.
Presence and development of diabetic retinopathy in 16 999 patients with type 1 diabetes in the Danish Registry of Diabetic Retinopathy.
Stokholm L, Pedersen FN, Andersen N, Andresen J, Bek T, Dinesen S, Hajari J, Heegaard S, Højlund K, Laugesen CS, Kawasaki R, Möller S, Schielke KC, Subhi Y, Thykjær AS, Grauslund J. Stokholm L, et al. Among authors: hojlund k. Acta Ophthalmol. 2024 May 18. doi: 10.1111/aos.16707. Online ahead of print. Acta Ophthalmol. 2024. PMID: 38761021
Initiation of glucose-lowering drugs reduces the anticoagulant effect of warfarin-But not through altered drug metabolism in patients with type 2 diabetes.
Dunvald AD, Nielsen F, Olsen DA, Ernst MT, Donnelly L, Soto-Pedre E, Kristiansen MR, Nielsen JS, Persson F, Højlund K, Madsen JS, Søndergaard J, Pearson E, Pottegård A, Stage TB. Dunvald AD, et al. Among authors: hojlund k. Br J Clin Pharmacol. 2023 Aug;89(8):2529-2541. doi: 10.1111/bcp.15725. Epub 2023 Apr 14. Br J Clin Pharmacol. 2023. PMID: 36967527
222 results